your market intelligence analyst
Search Results
53 results
Your search is now limited to «Prostate Cancer» expert search. 07/23/2019 07:03
Therefore, the Scandinavian Prostate Cancer Group (SPCG) are running a large multi-centre randomised control trial (RCT) to test the safety of a standardized active surveillance protocol with specific triggers for repeat biopsies and initiation of curative treatment, compared to ...
Sorry again for disjointed message. I find this system very erratic. From personal experience I suggest you consider the pump as part of Plan A. I struggled with ED for a year taking sildenafil only. I also tried taking tadalafil. (NOT together), it lasts for longer than sildenafil. I found function came and went and often started out OK but then failed at the vital moment. This was a psychological aspect as it annihilates your confidence. I saw a psychosexual .counsellor (with my partner) and that helped, but after the first year I tried the pump and it made a great difference and I wished I'd tried it earlier. I appreciate it seems a bit sordid and it was a bit embarassing going through the process of getting one but it worked very well f.
Business Wire 07/22/2019 06:19
BEERSE, Bélgica--(BUSINESS WIRE)--Las compañías farmacéuticas Janssen de Johnson & Johnson evalúan positivamente el reciente anuncio de la Organización Mundial de la Salud (OMS) sobre la inclusión del acetato de abiraterona (ZYTIGA ®) para el tratamiento del cáncer de próstata metastásico resistente a la castración (mCRPC) en la lista actualizada de medicamentos esenciales, publicada el 9 de julio de 2019.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios